000 | 01487 a2200385 4500 | ||
---|---|---|---|
005 | 20250514051938.0 | ||
264 | 0 | _c20021126 | |
008 | 200211s 0 0 eng d | ||
022 | _a1539-3704 | ||
040 |
_aNLM _beng _cNLM |
||
245 | 0 | 0 |
_aSummaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force. _h[electronic resource] |
260 |
_bAnnals of internal medicine _cNov 2002 |
||
300 |
_aI48 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Patient Education Handout | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBreast Neoplasms _xchemically induced |
650 | 0 | 4 |
_aCholecystitis _xchemically induced |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 |
_aColorectal Neoplasms _xprevention & control |
650 | 0 | 4 |
_aCoronary Disease _xchemically induced |
650 | 0 | 4 |
_aDementia _xprevention & control |
650 | 0 | 4 |
_aEndometrial Neoplasms _xchemically induced |
650 | 0 | 4 |
_aEstrogen Replacement Therapy _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFractures, Bone _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xprevention & control |
650 | 0 | 4 |
_aPostmenopause _xphysiology |
650 | 0 | 4 | _aPrimary Prevention |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aStroke _xchemically induced |
650 | 0 | 4 |
_aThromboembolism _xchemically induced |
773 | 0 |
_tAnnals of internal medicine _gvol. 137 _gno. 10 _gp. I48 |
|
999 |
_c12242143 _d12242143 |